Conditions: Metastatic Breast Cancer
Keywords: Avastin MBC Breast Cancer Sutent
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 46
Healthy volunteers: no

Brief summary:
This is a multicenter, Phase II, randomized, controlled, open label trial designed to provide a preliminary assessment of the safety and efficacy of sunitinib when combined with bevacizumab and paclitaxel in patients who have not previously received chemotherapy for locally recurrent or metastatic breast cancer.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: bevacizumab intervention 2: sunitinib intervention 3: paclitaxel
Intervention descriptions: intervention 1: Intravenous repeating dose intervention 2: Oral repeating dose intervention 3: Intravenous repeating dose

Protocol document: